Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2000
10/31/2000CA2151724C Antipyretic and analgesic methods and compositions containing optically pure r-ketorolac
10/31/2000CA2116535C A method for treatment of patients with chronic liver disease
10/31/2000CA2096345C Avermectins and milbemycins to treat parasitic in dogs
10/31/2000CA2018875C Production of pyrrolopyrimidines and intermediates therefor
10/30/2000CA2306502A1 Process for preparing spray granules containing riboflavin
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/27/2000CA2307104A1 Human myoblast cell lines and their uses
10/27/2000CA2307022A1 Agent for enhancing cerebral acetylcholine release
10/27/2000CA2306574A1 Methods and compositions for treating age-related behavioral disorders in companion animals
10/26/2000WO2000063703A1 Use of azetidinone compounds
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063434A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA
10/26/2000WO2000063430A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy
10/26/2000WO2000063395A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000WO2000063379A2 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000WO2000063364A2 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000WO2000063361A2 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
10/26/2000WO2000063348A2 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/26/2000WO2000063251A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000WO2000063245A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063228A1 Ent-steroids as selectively active estrogens
10/26/2000WO2000063225A2 Macrolide antiinfective agents
10/26/2000WO2000063224A2 Macrolide antiinfective agents
10/26/2000WO2000063223A1 Novel 8a- and 9a-15-membered lactams
10/26/2000WO2000063222A2 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
10/26/2000WO2000063219A1 Platinum complexes for the treatment of cancer
10/26/2000WO2000063218A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
10/26/2000WO2000063213A1 Beta-lactamase inhibiting compounds
10/26/2000WO2000063211A1 Haloalkoxy imidazonaphthyridines
10/26/2000WO2000063210A1 Morphinoid compounds
10/26/2000WO2000063209A1 New compounds, their preparation and use
10/26/2000WO2000063208A1 Substituted imidazoles, their preparation and use
10/26/2000WO2000063206A2 Thiazolidinedione derivative and its use as antidiabetic
10/26/2000WO2000063205A2 Thiazolidinedione derivative and its use as antidiabetic
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063203A1 Piperidine-indole compounds having 5-ht6 affinity
10/26/2000WO2000063198A1 2,2-disubstituted cyclic ether derivatives and hair tonics containing the same
10/26/2000WO2000063197A1 Hydroxamic acid derivative
10/26/2000WO2000063193A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
10/26/2000WO2000063192A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them
10/26/2000WO2000063191A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
10/26/2000WO2000063190A1 New compounds, their preparation and use
10/26/2000WO2000063189A1 Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
10/26/2000WO2000063187A1 Fab i inhibitors
10/26/2000WO2000063181A1 Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins
10/26/2000WO2000063180A1 Bis-benzazoles and their use as antineoplastic agents
10/26/2000WO2000063179A1 Neurotrophin potentiators
10/26/2000WO2000063178A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
10/26/2000WO2000063175A2 Novel process
10/26/2000WO2000063172A1 N-substituted piperidine derivatives
10/26/2000WO2000063171A1 Tricyclic compounds
10/26/2000WO2000063170A1 Cyclobutene-3,4-dione derivatives as inhibitors of phosphodiesterase 5
10/26/2000WO2000063167A1 Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide
10/26/2000WO2000063166A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
10/26/2000WO2000063165A1 Mmp inhibitor
10/26/2000WO2000063161A1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes
10/26/2000WO2000063159A1 (-)-verbenone derivatives
10/26/2000WO2000063157A1 Disubstituted benzene derivatives
10/26/2000WO2000063153A1 New compounds, their preparation and use
10/26/2000WO2000063148A1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions
10/26/2000WO2000062819A1 Formulations for detecting asthma
10/26/2000WO2000062813A2 Cationic peg-lipids and methods of use
10/26/2000WO2000062812A1 Nutritional composition for improved cognitive performance
10/26/2000WO2000062811A1 Pharmaceutical combination, containing a renin-angiotensin-system inhibitor, especially to be used in conjunction with hormone replacement therapy
10/26/2000WO2000062810A1 An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport
10/26/2000WO2000062809A1 Proliferation inhibitor for androgen-independent tumor
10/26/2000WO2000062808A2 Cobalamin conjugates useful as antitumor agents
10/26/2000WO2000062806A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/26/2000WO2000062804A2 Identification of sortase gene
10/26/2000WO2000062801A2 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/26/2000WO2000062800A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/26/2000WO2000062799A1 Hcv combination therapy, containing ribavirin in association with antioxidants
10/26/2000WO2000062793A2 Pseudomycin antifungal compositions and methods for their use
10/26/2000WO2000062785A1 Remedies
10/26/2000WO2000062784A1 Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases
10/26/2000WO2000062783A2 Ketolide antibacterials
10/26/2000WO2000062782A1 Novel synthesis and crystallization of piperazine ring-containing compounds
10/26/2000WO2000062781A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000WO2000062780A1 Use of glucosylceramide synthesis inhibitors in therapy
10/26/2000WO2000062779A1 Combination of glucosylceramide synthesis inhibitors and glycolipid degrading enzyme in therapy
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000062777A1 Methods for treatment of sickle cell anemia
10/26/2000WO2000062776A1 Antifungal compositions
10/26/2000WO2000062775A1 Compositions and methods for increasing the bioavailability of lactone ring containing drugs
10/26/2000WO2000062774A1 Methods of treating clinical diseases with isoflavones
10/26/2000WO2000062773A1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
10/26/2000WO2000062772A1 Peroxisome activator-responsive receptor agonists
10/26/2000WO2000062771A1 Uses of phenylglycine derivatives
10/26/2000WO2000062770A1 Compounds useful as phosphotyrosine mimics
10/26/2000WO2000062769A2 Use of ap-1 activators to treat glaucoma and ocular hypertension
10/26/2000WO2000062768A1 Composition and method useful for treating colic
10/26/2000WO2000062767A2 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000062765A2 ESTROGEN RECEPTOR-β LIGANDS
10/26/2000WO2000062764A1 Gum pad for delivery of medication to mucosal tissues
10/26/2000WO2000062758A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000WO2000062757A1 Composition containing opioid antagonists and spray dispenser
10/26/2000WO2000062753A1 Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones
1 ... 6220 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 6233 6234 6235 6236 6237 6238 6239 6240 ... 7860